In the current study, it has been shown that our dual GLP-1/GIP receptor agonist can effectively improve hyperglycemia, including fasting blood glucose, glucose tolerance and glycosylated hemoglobin, in diabetic mice. Here, GCG is linked to Hyperglycemia.